Robuta

https://pubmed.ncbi.nlm.nih.gov/34272470/
Gatekeeper mutations are identified in only 50% of the cases at resistance to Anaplastic Lymphoma Kinase (ALK)-tyrosine kinase inhibitors (TKIs). Circulating...
circulating tumor cellcopy numberheterogeneityalknon
https://www.mdpi.com/2075-4418/10/3/151
Background: The AR-V7 splice variant is a cause of castration-resistant prostate cancer (CRPC).
circulating tumor cellnovelenrichmentmethodreduces